A longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral density

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 3, 1997, Pages 753-759

  Siddiqi, A ^a,b   Burrin, J M ^a   Noonan, K ^a   James, I ^a   Wood, D F ^a   Price, C P ^a   Monson, J P ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; CARBIMAZOLE; DEOXYPYRIDINOLINE; LIOTHYRONINE; OSTEOCALCIN; PROPRANOLOL; PYRIDINOLINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERALIZATION; BONE REMODELING; BONE TURNOVER; CLINICAL ARTICLE; CORTICAL BONE; DOSE RESPONSE; FEMALE; GRAVES DISEASE; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; THYROTOXICOSIS; TRABECULAR BONE;

ADULT; ANTITHYROID AGENTS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CARBIMAZOLE; FEMALE; FORECASTING; GRAVES DISEASE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; THYROTOXICOSIS;

EID: 0031044494     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.3.753     Document Type: Article

References (36)

1. Rizzoli R, Poser J, Burgi U. 1986 Nuclear thyroid hormone receptors in cultured bone cells. Metabolism. 35:71-74.
2. Britto JM, Fenton AJ, Holloway WR, Nicholson GC. 1994 Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology. 134:169-176.
3. Sato K, Han DC, Fujii Y, Tsushima T, Shizume K. 1994 Thyroid hormone stimulates alkaline phosphatase activity in cultured rat osteoblastic cells (ROS 17/2.8) through 3,5,3′-triiodothyronine nuclear receptors. Endocrinology. 120:1873-1881.
4. Ohishi K, Ishida H, Nagata T, et al. 1994 Thyroid hormone suppresses the differentiation of osteoprogenitor cells to osteoblasts, but enhances functional activities of mature osteoblasts in cultured rat calvaria cells. J Cell Physiol. 161:544-552.
5. Legovini P, De Menis E, Da Rin G, et al. 1994 Increased serum levels of carboxy-terminal propeptide of type 1 collagen (PICP) in hyperthyroidism. Horm Metab Res. 26:334-337.
6. Mosekilde L, Eriksen EF, Charles P. 1990 Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am. 19:35-63.
7. Franklyn J, Betteridge J, Holder R, Daykin J, Lilley J, Sheppard M. 1994 Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis. Clin Endocrinol (Oxf). 41:425-432.
8. Bayley TA, Harrison JE, McNeill KG, Mernagh JR. 1980 Effect of thyrotoxicosis and its treatment on bone mineral and muscle mass. J Clin Endocrinol Metab. 50:916-922.
9. Toh SH, Claunch BC, Brown PH. 1985 Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med. 145:883-886.
10. Krolner B, Jorgensen JV, Nielsen SP. 1983 Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol (Oxf). 18:439-446.
11. Rosen CJ, Adler RA. 1992 Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab. 75:1531-1534.
12. Tibi L, Patrick AW, Leslie P, Toft AD, Smith AF. 1989 Alkaline phosphatase isoenzymes in plasma in hyperthyroidism. Clin Chem. 35:1427-1430.
13. Lee MS, Kim SY, Lee MC, et al. 1990 Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab. 70:766-770.
14. Harvey D, McHardy C, Reid IW, et al. 1991 Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J Clin Endocrinol Metab. 72:1189-1194.
15. Cooper DS, Kaplan MM, Ridgeway EC, Maloof F, Daniels GH. 1979 Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann Intern Med. 90:164-168.
16. Faber J, Perrild H, Johansen JS. 1989 Serum bone Gla protein (BGP) during treatment of hyperthyroidism and hypothyroidism. Horm Metab Res. 23:135-138.
17. Garrel DR, Delmas PD, Malaval L, Tournaire J. 1986 Serum bone Gla protein: a marker of bone turnover in hyperthyroidism. J Clin Endocrinol Metab. 62:1052-1055.
18. Garnero P, Vassy V, Bertholin A, Riou JP, Delmas PD. 1994 Markers of bone turnover in hyperthyroidism and the effects of treatment. J Clin Endocrinol Metab. 78:955-959.
19. Hermus AR, Smals AG, Swinkles LM, et al. 1995 Bone mineral density and bone turnover before and after surgical cure of Cushing's Syndrome. J Clin Endocrinol Metab. 80:2859-2865.
20. Pecherstorfer M, Zimmer-Roth I, Schilling T, et al. 1995 The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase and urinary calcium excretion in neoplastic bone disease. J Clin Endocrinol Metab. 80:97-103.
21. Weaver JU, Monson JP, Noonan K, et al. 1996 The effect of low dose recombinant human growth hormone replacement on indices of bone remodelling and bone mineral density in hypopituitary growth hormone-deficient adults. Endocrinol Metab Clin North Am. 3:55-61.
22. Kushida K, Takahashi M, Kawana K, Inoue T. 1995 Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects and osteoporosis patients. J Clin Endocrinol Metab. 80:2447-2450.
23. Ohishi T, Kushida K, Takahashi M, et al. 1994 Urinary bone resorption markers in patients with metabolic bone disorders. Bone. 15:15-20.
24. Wishart JM, Need AG, Horowitz M, Morris HA, Nordin BEC. 1995 Effect of age on bone density and bone turnover in men. Clin Endocrinol (Oxf). 42:141-146.
25. Silverberg SJ, Gartenberg F, Jacobs TP, et al. 1995 Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab. 80:729-734.
26. Wenisch C, Bankl HC, Schonthal E, et al. 1995 Serum levels of the carboxy-terminal cross-linked telopeptide of type 1 collagen and laminin are elevated in Graves' disease but not in toxic nodular goitre. Clin Immunol Immunopathol. 75:225-230.
27. Kagibayashi Y, Samma S, Yoneda T, et al. 1995 Measurement and clinical significance of serum concentrations of pyridinium cross-links in patients with renal osteodystrophy. Nippon Jinzo Gakkai Shi. 37:397-403.
28. James I, Crowley C, Perrett D. 1993 Assay of pyridinium crosslinks in serum using narrow ion-paired reversed-phase high performance liquid chromatography. J Chromatogr. 612:41-48.
29. Eastell R, Robins SP, Colwell T, Assiri AMA, Riggs BL, Russell RGG. 1993 Evaluation of bone turnover in type 1 osteoporosis using biochemical markers for both bone formation and bone resorption. Osteoporos Int. 3:255-260.
30. Crofton PM, Stirling HF, Schonau E, Kelnar CJH. 1995 Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children. Clin Endocrinol (Oxf). 44:385-394.
31. Moro L, Gazzarrini C, Crivellari D, Galligioni E, Talamini R, de Bernard B. 1993 Biochemical markers for detecting bone metastases in patients with breast cancer. Clin Chem. 39:131-134.
32. Eastell R, Peel NFA. 1994 Interpretation of bone density results. Osteoporosis Rev. 2:1-4.
33. Eastell R, Riggs BL. 1988 Diagnostic evaluation of osteoporosis. Endocrinol Metab Clin North Am. 17:547-572.
34. Hui SL, Slemenda CW, Johnson Jr CC. 1989 Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med. 111:355-361.
35. Wasnich RD. 1987 Fracture prediction with bone mass measurements. In: Genant HK, ed. Osteoporosis update 1987. San Francisco: Radiology Research and Education Foundation; 95-101.
36. Wasnich RD, Ross PD, Davis JW, Vogel JM. 1989 A comparison of single and multisite BMC measurements for assessment of spine fracture probability. J Nucl Med. 30:1166-1171.